Fertility status in childhood cancer survivors of hematological malignancies: a systematic review

[1]  F. Drago,et al.  Fertility Preservation in Female Pediatric Patients With Cancer: A Clinical and Regulatory Issue , 2021, Frontiers in Oncology.

[2]  A. Cymbaluk-Płoska,et al.  Fertility Preservation and Long-Term Monitoring of Gonadotoxicity in Girls, Adolescents and Young Adults Undergoing Cancer Treatment , 2021, Cancers.

[3]  Richard A. Anderson,et al.  Cancer survivorship: Reproductive health outcomes should be included in standard toxicity assessments. , 2020, European journal of cancer.

[4]  P. Nathan,et al.  Predicting acute ovarian failure in female survivors of childhood cancer: a cohort study in the Childhood Cancer Survivor Study (CCSS) and the St Jude Lifetime Cohort (SJLIFE). , 2020, The Lancet Oncology.

[5]  Yunyun Wang,et al.  Management of non-muscle-invasive bladder cancer: quality of clinical practice guidelines and variations in recommendations , 2019, BMC Cancer.

[6]  A. Mertens,et al.  Early Detection of Ovarian Dysfunction by Anti-Mullerian Hormone in Adolescent and Young Adult-Aged Survivors of Childhood Cancer. , 2019, Journal of adolescent and young adult oncology.

[7]  A. Giwercman,et al.  Anti-müllerian hormone compared with other ovarian markers after childhood cancer treatment , 2019, Acta oncologica.

[8]  M. Hauptmann,et al.  Long-term effects of childhood cancer treatment on hormonal and ultrasound markers of ovarian reserve , 2018, Human reproduction.

[9]  M. Hudson,et al.  Reproductive Function and Outcomes in Female Survivors of Childhood, Adolescent, and Young Adult Cancer: A Review. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  U. Selek,et al.  Ovarian and Uterine Functions in Female Survivors of Childhood Cancers. , 2018, The oncologist.

[11]  Michael W. Bishop,et al.  Premature Ovarian Insufficiency in Childhood Cancer Survivors: A Report From the St. Jude Lifetime Cohort , 2017, The Journal of clinical endocrinology and metabolism.

[12]  A. Mertens,et al.  Low Anti-Müllerian Hormone in Pediatric Cancer Survivors in the Early Years after Gonadotoxic Therapy. , 2016, Journal of pediatric and adolescent gynecology.

[13]  M. Hudson,et al.  Fertility preservation in children , adolescents , and young adults with cancer , 2016 .

[14]  C. Siristatidis,et al.  Fertility Risk Assessment and Preservation in Male and Female Prepubertal and Adolescent Cancer Patients , 2016, Clinical Medicine Insights. Oncology.

[15]  I. Yakoub-Agha,et al.  Immunosuppressive drugs and fertility , 2015, Orphanet Journal of Rare Diseases.

[16]  I. Vakalopoulos,et al.  Impact of cancer and cancer treatment on male fertility , 2015, Hormones.

[17]  W. Klapper,et al.  Non-Hodgkin Lymphoma in Children and Adolescents: Progress Through Effective Collaboration, Current Knowledge, and Challenges Ahead. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  A. Baruchel,et al.  Ovarian reserve after treatment with alkylating agents during childhood. , 2015, Human reproduction.

[19]  E. Çalışkan,et al.  The effect of childhood cancer therapy on ovarian reserve and pubertal development. , 2015, Reproductive biomedicine online.

[20]  P. Shekelle,et al.  Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement , 2015, Systematic Reviews.

[21]  K. McCormick,et al.  Antimüllerian hormone as a measure of reproductive function in female childhood cancer survivors. , 2014, Fertility and sterility.

[22]  A. Juul,et al.  Pubertal development and fertility in survivors of childhood acute myeloid leukemia treated with chemotherapy only: A NOPHO‐AML study , 2013, Pediatric blood & cancer.

[23]  K. Schmiegelow,et al.  A 10-year follow up of reproductive function in women treated for childhood cancer. , 2013, Reproductive biomedicine online.

[24]  A. El-Shalakany,et al.  Ovarian Function in Female Survivors of Childhood Malignancies , 2013, Pediatric hematology and oncology.

[25]  A. Uitterlinden,et al.  Genetic variation may modify ovarian reserve in female childhood cancer survivors. , 2013, Human reproduction.

[26]  S. Missmer,et al.  Ovarian Reserve in Women Treated for Acute Lymphocytic Leukemia or Acute Myeloid Leukemia with Chemotherapy, but Not Stem Cell Transplantation , 2012, ISRN oncology.

[27]  Richard A. Anderson,et al.  Anti-Müllerian hormone is a marker of gonadotoxicity in pre- and postpubertal girls treated for cancer: a prospective study. , 2012, The Journal of clinical endocrinology and metabolism.

[28]  T. Keil,et al.  Suspected infertility after treatment for leukemia and solid tumors in childhood and adolescence. , 2012, Deutsches Arzteblatt international.

[29]  M. Sammel,et al.  Impact of cancer therapies on ovarian reserve. , 2012, Fertility and sterility.

[30]  M. Hudson.  Reproductive Outcomes for Survivors of Childhood Cancer , 2010, Obstetrics and gynecology.

[31]  R. Johnston,et al.  Normal ovarian function and assessment of ovarian reserve in the survivor of childhood cancer , 2009, Pediatric blood & cancer.

[32]  D. Green,et al.  Fertility of female survivors of childhood cancer: a report from the childhood cancer survivor study. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  D. Green,et al.  Ovarian failure and reproductive outcomes after childhood cancer treatment: results from the Childhood Cancer Survivor Study. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  D. Orbach,et al.  Testicular function of survivors of childhood cancer: a comparative study between ifosfamide- and cyclophosphamide-based regimens. , 2009, European journal of cancer.

[35]  R. Pieters,et al.  Anti-Mullerian hormone is a sensitive serum marker for gonadal function in women treated for Hodgkin's lymphoma during childhood. , 2007, The Journal of clinical endocrinology and metabolism.

[36]  D. Green,et al.  Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study. , 2006, Journal of the National Cancer Institute.

[37]  P. Patrizio,et al.  American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  M. Davies,et al.  Fertility in female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testing. , 2005, Human reproduction update.

[39]  S. Shalet,et al.  The impact of cancer therapy on the endocrine system in survivors of childhood brain tumours. , 2004, Endocrine-related cancer.

[40]  T. Fears,et al.  Fertility in women treated with cranial radiotherapy for childhood acute lymphoblastic leukemia , 2004, Pediatric blood & cancer.

[41]  T. Fears,et al.  Fertility of long‐term male survivors of acute lymphoblastic leukemia diagnosed during childhood , 2004, Pediatric blood & cancer.

[42]  K. Schmiegelow,et al.  Reduced ovarian function in long-term survivors of radiation- and chemotherapy-treated childhood cancer. , 2003, The Journal of clinical endocrinology and metabolism.

[43]  R. Anderson,et al.  Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Müllerian hormone, inhibin B and ovarian ultrasound. , 2003, Human reproduction.

[44]  Michael J Thun,et al.  Long‐term trends in cancer mortality in the United States, 1930–1998 , 2003, Cancer.

[45]  C. Kelnar,et al.  Late reproductive sequelae following treatment of childhood cancer and options for fertility preservation. , 2002, Best practice & research. Clinical endocrinology & metabolism.

[46]  R. Anderson,et al.  Hypothalamic-pituitary-ovarian dysfunction after prepubertal chemotherapy and cranial irradiation for acute leukaemia. , 2001, Human reproduction.

[47]  E. Nieschlag,et al.  The effects of different cumulative doses of chemotherapy on testicular function. Results in 75 patients treated for Hodgkin's disease during childhood or adolescence , 1990, Cancer.

[48]  R. Hoover,et al.  Leukemia after therapy with alkylating agents for childhood cancer. , 1987, Journal of the National Cancer Institute.

[49]  E. W. Hahn,et al.  Recovery from aspermia induced by low‐dose radiation in seminoma patients , 1982 .

[50]  E. W. Hahn,et al.  Recovery from aspermia induced by low‐dose radiation in seminoma patients , 1980, Cancer.